Ketogenic Diet in Cancer Prevention and Therapy: Molecular Targets and Therapeutic Opportunities

Wamidh H Talib1, Asma Ismail Mahmod1, Ayah Kamal1

  • 1Department of Clinical Pharmacy and Therapeutics, Applied Science Private University, Amman 11931, Jordan.

Insights

The ketogenic diet (KD), a high-fat, low-carb diet, shows promise as an adjuvant cancer therapy. It creates an unfavorable metabolic environment for cancer cells, potentially enhancing standard treatments.

Area of Science:

  • Oncology
  • Nutritional Science
  • Metabolic Medicine

Background:

  • Cancer remains a major global health challenge, necessitating novel therapeutic strategies.
  • Standard cancer treatments can be enhanced by complementary approaches, including dietary interventions.
  • The ketogenic diet (KD) is emerging as a metabolic therapy targeting cancer cell metabolism.

Purpose of the Study:

  • To review the mechanisms underlying the ketogenic diet's potential antitumor effects.
  • To explore the KD as an adjuvant therapy in cancer treatment.
  • To provide a foundation for developing combination therapies involving KD and conventional treatments.

Main Methods:

  • Literature review of studies investigating the ketogenic diet in cancer.
  • Analysis of the metabolic mechanisms of KD concerning cancer cell energy supply.
  • Evaluation of KD's potential to create an unfavorable environment for tumor growth.

Main Results:

  • The ketogenic diet (KD) is characterized by high fat, very low carbohydrate, and adequate protein intake.
  • KD demonstrates antitumor effects by reducing energy substrates available to cancer cells.
  • This metabolic shift inhibits tumor growth and proliferation.

Conclusions:

  • The ketogenic diet exhibits potential antitumor effects through metabolic manipulation.
  • KD may serve as a promising adjuvant therapy to enhance conventional cancer treatments.
  • Further research can guide the integration of KD into combination cancer therapies.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.8K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
7.0K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.1K